新生儿缺氧缺血性脑病治疗研究进展

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (696 KB) HTML (38 KB)
输出: BibTeX | EndNote (RIS)

摘要新生儿缺氧缺血性脑病(HIE)是神经系统受损的重要原因,发病率高达13‰,其中25-30%的婴儿患有永久性神经损伤,包括脑瘫、癫痫、精神障碍、视力和听力障碍以及认知和学习障碍,给家庭带来了巨大的精神和经济负担,也给全球公共卫生事业带来了挑战。亚低温治疗是支持治疗外,唯一公认有效的神经保护治疗措施,在一定程度上降低了HIE的死亡率和残疾率。研究者们致力于探索新的治疗方法,作为亚低温治疗的辅助治疗或独立应用于HIE。本文综述了新生儿缺氧缺血性脑病的治疗研究进展,着重于足月儿及晚期早产儿,以期进一步降低HIE的死亡率、致残率和改善神经发育预后。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	肖湘
	陈欣萌
	曾琳
	韩彤妍

关键词 ：新生儿缺氧缺血性脑病, 新生儿, 足月儿及晚期早产儿, 治疗

收稿日期: 2023-02-08

ZTFLH:	R71
	R72

通讯作者: 韩彤妍(tongyanhan@qq.com)

引用本文:

肖湘, 陈欣萌, 曾琳, 韩彤妍. 新生儿缺氧缺血性脑病治疗研究进展[J]. 中国生育健康杂志, 2024, 35(1): 89-93.

链接本文:

http://cjrh.bjmu.edu.cn/CN/ 或 http://cjrh.bjmu.edu.cn/CN/Y2024/V35/I1/89

1 Shipley L,Gale C,Sharkey D.Trends in the incidence and management of hypoxic-ischaemic encephalopathy in the therapeutic hypothermia era:a national population study.Arch Dis Child Fetal Neonatal Ed,2021,106:529-534.
2 Li B,Concepcion K,Meng X,et al.Brain-immune interactions in perinatal hypoxic-ischemic brain injury.Prog Neurobiol,2017,159:50-68.
3 Saugstad OD.Reducing global neonatal mortality is possible.Neonatology,2011,99:250-257.
4 Barrett RD,Bennet L,Naylor A,et al.Effect of cerebral hypothermia and asphyxia on the subventricular zone and white matter tracts in preterm fetal sheep.Brain Res,2012,1469:35-42.
5 Rao R,Trivedi S,Vesoulis Z,et al.Safety and short-term outcomes of fherapeutic hypothermia in preterm neonates 34-35 weeks gestational age with hypoxic-ischemic encephalopathy.J Pediatr,2017,183:37-42.
6 Lademann H,Abshagen K,Janning A,et al.Long-term outcome after asphyxia and therapeutic hypothermia in late preterm Infants:a pilot study.Healthcare(Basel),2021,9:994.
7 Herrera TI,Edwards L,Malcolm WF,et al.Outcomes of preterm infants treated with hypothermia for hypoxic-ischemic encephalopathy.Early Hum Dev,2018,125:1-7.
8 Wassink G,Davidson JO,Dhillon SK,et al.Partial white and grey matter protection with prolonged infusion of recombinant human erythropoietin after asphyxia in preterm fetal sheep.J Cereb Blood Flow Metab,2017,37:1080-1094.
9 Oorschot DE,Sizemore RJ,Amer AR.Treatment of neonatal hypoxic-ischemic encephalopathy with erythropoietin alone,and erythropoietin combined with hypothermia:history,current status,and future research.Int J Mol Sci,2020,21:1487.
10 Pang R,Avdic-Belltheus A,Meehan C,et al.Melatonin and/or erythropoietin combined with hypothermia in a piglet model of perinatal asphyxia.Brain Commun,2020,3:fcaa211.
11 Zhu C,Kang W,Xu F,et al.Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy.Pediatrics,2009,124:e218-226.
12 Malla RR,Bhat MA.Erythropoietin monotherapy in perinatal asphyxia with moderate to severe encephalopathy:a randomized placebo-controlled trial.J Perinatol,2018,38:294.
13 王淑云.亚低温联合VitC、EPO治疗对新生儿窒息患儿靶器官损伤的影响.海南医学院学报,2017,23:2705-2707,2711.
14 Juul SE,Comstock BA,Wadhawan R,et al.A randomized trial of erythropoietin for neuroprotection in preterm infants.N Engl J Med,2020,382:233-243.
15 Wu YW,Comstock BA,Gonzalez FF,et al.Trial of erythropoietin for hypoxic-ischemic encephalopathy in newborns.N Engl J Med,2022,387:148-159.
16 Kellert BA,McPherson RJ,Juul SE.A comparison of high-dose recombinant erythropoietin treatment regimens in brain-injured neonatal rats.Pediatr Res,2007,61:451-455.
17 Wu YW,Bauer LA,Ballard RA,et al.Erythropoietin for neuroprotection in neonatal encephalopathy:safety and pharmacokinetics.Pediatrics,2012,130:683-691.
18 Sun Y,Ma L,Jin M,et al.Effects of melatonin on neurobehavior and cognition in a cerebral palsy model of plppr5-/-mice.Front Endocrinol(Lausanne),2021,12:598788.
19 Aridas JD,Yawno T,Sutherland AE,et al.Melatonin augments the neuroprotective effects of hypothermia in lambs following perinatal asphyxia.J Pineal Res,2021,71:e12744.
20 Pang R,Han HJ,Meehan C,et al.Efficacy of melatonin in term neonatal models of perinatal hypoxia-ischaemia.Ann Clin Transl Neurol,2022,9:795-809.
21 Ahmad QM,Chishti AL,Waseem N.Role of melatonin in management of hypoxic ischaemic encephalopathy in newborns:A randomized control trial.J Pak Med Assoc,2018,68:1233-1237.
22 Jerez-Calero A,Salvatierra-Cuenca MT,Benitez-Feliponi á,et al.Hypothermia plus melatonin in asphyctic newborns:a randomized-controlled pilot study.Pediatr Crit Care Med,2020,21:647-655.
23 Marseglia L,Gitto E,Laschi E,et al.Antioxidant effect of melatonin in preterm newborns.Oxid Med Cell Longev,2021,2021:6308255.
24 Ahmed J,Pullattayil S AK,Robertson NJ,et al.Melatonin for neuroprotection in neonatal encephalopathy:A systematic review & meta-analysis of clinical trials.Eur J Paediatr Neurol,2021,31:38-45.
25 Ma Q.Role of nrf2 in oxidative stress and toxicity.Annu Rev Pharmacol Toxicol,2013,53:401-426.
26 Le Nogue D,Lavaur J,Milet A,et al.Neuroprotection of dopamine neurons by xenon against low-level excitotoxic insults is not reproduced by other noble gases.J Neural Transm(Vienna),2020,127:27-34.
27 Filev AD,Silachev DN,Ryzhkov IA,et al.Effect of xenon treatment on gene expression in brain tissue after traumatic brain injury in rats.Brain Sci,2021,11:889.
28 Dingley J,Tooley J,Liu X,et al.Xenon ventilation during therapeutic hypothermia in neonatal encephalopathy:a feasibility study.Pediatrics,2014,133:809-818.
29 Azzopardi D,Robertson NJ,Bainbridge A,et al.Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe):a proof-of-concept,open-label,randomised controlled trial.Lancet Neurol,2016,15:145-153.
30 Ma S,Chu D,Li L,et al.Argon inhalation for 24 hours after onset of permanent focal cerebral ischemia in rats provides neuroprotection and improves neurologic outcome.Crit Care Med,2019,47:e693-e699.
31 Broad KD,Fierens I,Fleiss B,et al.Inhaled 45-50% argon augments hypothermic brain protection in a piglet model of perinatal asphyxia.Neurobiol Dis,2016,87:29-38.
32 Loetscher PD,Rossaint J,Rossaint R,et al.Argon:neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury.Crit Care,2009,13:R206.
33 Feng Z,Liu J,Ju R.Hyperbaric oxygen treatment promotes neural stem cell proliferation in the subventricular zone of neonatal rats with hypoxic-ischemic brain damage.Neural Regen Res,2013,8:1220-1227.
34 Gong XB,Feng RH,Dong HM,et al.Efficacy and prognosis of hyperbaric oxygen as adjuvant therapy for neonatal hypoxic-ischemic encephalopathy:a meta-analysis study.Front Pediatr,2022,10:707136.
35 刘滢,蒋红斌,赵宇琳,等.高压氧结合亚低温治疗新生儿缺氧缺血性脑病的临床效果.华夏医学,2022,35:128-130.
36 Tsuji M,Taguchi A,Ohshima M,et al.Effects of intravenous administration of umbilical cord blood CD34(+) cells in a mouse model of neonatal stroke.Neuroscience,2014,263:148-158.
37 Serrenho I,Rosado M,Dinis A,et al.Stem cell therapy for neonatal hypoxic-ischemic encephalopathy:a systematic review of preclinical studies.Int J Mol Sci,2021,22:3142.
38 Robertson NJ,Meehan C,Martinello KA,et al.Human umbilical cord mesenchymal stromal cells as an adjunct therapy with therapeutic hypothermia in a piglet model of perinatal asphyxia.Cytotherapy,2021,23:521-535.
39 Herz J,Kster C,Reinboth BS,et al.Interaction between hypothermia and delayed mesenchymal stem cell therapy in neonatal hypoxic-ischemic brain injury.Brain Behav Immun,2018,70:118-130.
40 Penny TR,Pham Y,Sutherland AE,et al.Multiple doses of umbilical cord blood cells improve long-term brain injury in the neonatal rat.Brain Res,2020,1746:147001.
41 Cotten CM,Murtha AP,Goldberg RN,et al.Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy.J Pediatr,2014,164:973-979.e1.